ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 578

Restricted Work Participation Relates to High Disease Activity in Spondyloarthritis Patients

Ann-Sophie De Craemer1, Thomas Renson 1, Liselotte Deroo 1, Philippe Carron 1, Annelies Boonen 2, Xavier Janssens 3, Dirk Elewaut 1 and Filip Van den Bosch 1, 1Ghent University Hospital, Ghent, Belgium, 2Maastricht University Medical Center, Maastricht, Netherlands, 3AZ Sint-Lucas, Gent, Belgium

Meeting: ACR/ARP Annual Meeting 2019

Keywords: spondyloarthritis, Work Disability and Employment

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Axial Spondyloarthritis, Clinical Features

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Spondyloarthritis (SpA) generally affects patients at a working age. Despite therapeutic improvements, SpA remains responsible for a significant burden for patients and society in terms of sick leave and work disability. This study aims to assess the determinants of work participation in a Belgian SpA cohort.

Methods: Between May 1st 2018 and April 1st 2019, a cross-sectional survey was conducted amongst patients included in a Belgian SpA cohort ((Be-)Giant), all fulfilling ASAS classification criteria for axial or peripheral SpA. Information on work participation was collected using the Work Productivity and Activity Impairment (WPAI) questionnaire. Physicians’ assessment included standardized clinical and laboratory evaluations. Outcomes of interest were employment status (being employed yes/no), absenteeism (percentage of time absence from the workplace), presenteeism (percentage of productivity loss while at work) and percentage of overall work impairment. Continuous outcomes were categorized because of skewed (zero inflated) distributions. The associations between the four outcomes of interest and patient characteristics were modelled using univariate and multivariate logistic regression. The sample was restricted to SpA patients of working age (≤65 years old).

Results: Data were collected on 262 patients: 214 (81.7%) were employed, 26 (9.9%) work disabled, 8 (3.1%) unemployed, 8 (3.1%) student, 5 (1.9%) early retired and 1 (0.4%) housekeeper. Table 1 summarizes demographic and clinical characteristics. Table 2 shows univariate associations between patient characteristics and the outcomes of interest. Gender, age, symptom duration and SpA subtype are not significantly associated with any of the four outcomes. Higher education increases the odds of being employed and reduces the odds of absenteeism. Manual labour, high ASDAS-CRP and high BASFI show a negative association with employment and significantly increase the odds of absenteeism, presenteeism and overall work impairment. After multivariate adjustment, only ASDAS-CRP and BASFI showed a significant association with employment  status (OR 0.39 and 0.69), absenteeism (OR 2.54 and 1.71), presenteeism (OR 2.58 and 1.81) and work impairment (OR 2.67 and 1.82) (all p < 0,05).

Conclusion: High disease activity and functional impairment are significantly associated with work participation and overall work impairment in a Belgian SpA cohort. Of interest, neither gender, age, symptom duration, type of work nor SpA subtype significantly affect any of the work-related outcomes. Given the important health economic impact of employment rate in our society, this underscores the need for tight disease control in patients with SpA.

Table 1: Demographic and clinical characteristics

Table 2: Association between patient characteristics and work-related outcomes. -*p<0.05-


Disclosure: A. De Craemer, None; T. Renson, None; L. Deroo, None; P. Carron, None; A. Boonen, AbbVie, 2, Amgen, 2, Celgene, 2, Eli Lilly and Company, 5, Janssen, 8, Lilly, 5, 8, Novartis, 5, Sandoz, 5, 8, UCB, 5, 8; X. Janssens, None; D. Elewaut, None; F. Van den Bosch, AbbVie, 5, 8, Abbvie, 5, 8, AbbVie, Bristol-Myers Squibb, Celgene, Galapagos, Janssen, Lilly, MSD, Novartis, Pfizer, Sanofi and UCB, 5, 8, ABBVIE, CELGENE, ELI LILLY, GALAPAGOS, MERCK, NOVARTIS, PFIZER, VCB, 5, 8, Bristol-Myers Squibb, 2, 5, 8, Celgene, 5, 8, Eli Lilly, 5, 8, Galapagos, 5, 8, Janssen, 5, 8, Merck, 5, 8, Novartis, 5, 8, Pfizer, 5, 8, Sanofi, 5, 8, UCB, 5, 8.

To cite this abstract in AMA style:

De Craemer A, Renson T, Deroo L, Carron P, Boonen A, Janssens X, Elewaut D, Van den Bosch F. Restricted Work Participation Relates to High Disease Activity in Spondyloarthritis Patients [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/restricted-work-participation-relates-to-high-disease-activity-in-spondyloarthritis-patients/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR/ARP Annual Meeting 2019

ACR Meeting Abstracts - https://acrabstracts.org/abstract/restricted-work-participation-relates-to-high-disease-activity-in-spondyloarthritis-patients/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology